UK Developing New COVID-19 Treatment Alternative From Vaccine

Medicine & Technology Dec 30, 2020

AstraZeneca recruited their first participants as part of a study of a new long-acting COVID-19 antibody treatment.

AstraZeneca Says COVID-19 Vaccine Has A 'Winning Formula;' Will It Work On New COVID-19 Strain?

Dec 29, 2020

Experts are studying the possibility of giving instant long-term immunity to high-risk COVID-19 patients using AstraZeneca's vaccine. Is AstraZeneca winning?

COVID-19 Vaccine: How Will It Be Distributed Among Countries?

Dec 01, 2020

COVID-19 vaccine developers have already reported promising Phase III results. But who will get the vaccine first?

After AstraZeneca’s Admission of Error, Difficult Questions About its Vaccines Transpire

Nov 26, 2020

AstraZeneca recognized a key error in the vaccine dosage which some study participants received, about the apparently spectacular efficacy of its vaccine is now in question.

Oxford University COVID-19 Vaccine Shows 70% Effectiveness

Nov 23, 2020

The vaccine developed in the UK by AstraZeneca and Oxford University ‘will save many lives,’ says scientist.

AstraZeneca's Vaccine Candidate Produces Antibodies and T-Cell Protection for Up to One Year

Oct 26, 2020

With AstraZeneca's vaccine trials resuming worldwide, results have shown good immune responses in young and older adults alike. However, trials are yet to resume in the United States as volunteers await their second dose.

The U.S. Records Highest Covid-19 Cases in One Day Since the Pandemic Began

Oct 24, 2020

Over 80,000 new coronavirus cases were reported in a single day this week in the United States. Experts fear that despite promises of an available vaccine within months, the winter season may be the worst season of the pandemic. Dr. Fauci also proposes that wearing face masks should be mandated.

Astrazeneca's COVID-19 Vaccine Trials to Continue Even After A Volunteer Dies

Oct 22, 2020

Following the review of one volunteer's death in Astrazeneca and Oxford's COVID-19 vaccine trial, authorities said the clinical trials would continue.

AstraZeneca Temporarily Stops Phase 3 of Global Vaccine Trials

Sep 09, 2020

AstraZeneca, already in the late-stage of their phase three vaccine trials, had to pause all trials due to one volunteer developing an unexplained illness. Alongside other Operation Warp Speed Companies, the biopharmaceutical company signed a joint pledge to properly follow scientific and ethical standards in developing a coronavirus vaccine.

A Clinical Study Finds Pfizer's Dacomitinib Delays The Growth of Lung Cancer Cells Better Than AstraZeneca's Iressa

Jun 06, 2017

In the last day of ASCO 2017 annual meeting on Tuesday, researchers presented the data of Dacomitinib that delayed the growth of the lung cancer longer than Gefitinib, trademarked as Iressa in newly diagnosed patients.

FDA Grants Approval To AstraZeneca's New Lung Cancer Pill

Nov 16, 2015

The Food and Drug Administration (FDA) recently approved a new lung cancer pill, called AZD9291 or Tagrisso, from AstraZeneca after its two-year clinical trial with promising results.

AstraZeneca's Contribution To Cancer Eradication

Aug 11, 2015

AstraZeneca has made its third big deal this week involving a new cancer drug, in its aim to eradicate the disease.